MedPath

Effect of Two Different Rye Bread Types in Irritable Bowel Syndrome

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Other: Traditional Finnish rye bread
Other: Low FODMAP rye bread
Registration Number
NCT02161120
Lead Sponsor
Oy Karl Fazer Ab
Brief Summary

The purpose of this study is to evaluate if low-FODMAP (Fermented Oligo-, Di-, Monosaccharides And Polyols) rye bread is better tolerated in irritable bowel syndrome than commonly available traditional rye bread higher in FODMAP carbohydrates. The study also aims to investigate patients' compliance to rye bread regimen, potential changes is gut microbiota and hydrogen production during the test periods (a marker of large bowel fermentation of poorly absorbed carbohydrates).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • IBS according to Rome III criteria. Accepted sub-types include IBS-M, IBS-D and IBS-U
  • Age 18-65 years
  • Willing to use rye bread daily during the study periods
Exclusion Criteria
  • IBS-C (constipation dominant)
  • Celiac disease
  • IBD
  • Major gastrointestinal operations like bowel gastric resection
  • Non-treated hypo- or hyperthyroidism
  • Alcoholism, severe depression, dementia, cancer or other diseases likely to severly impair the participants ability to conclude the protocol
  • Regular (almost daily) use of NSAIDs, antibiotics or lactulose
  • Linaclotide and other prescription medicines targeted specifically to IBS
  • Pregnancy and lactation
  • Follows currently strict low-FODMAP diet

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Traditional rye breadTraditional Finnish rye breadAs part of habitual diet participants are expected to consume 100-200 grams of traditional Finnish rye bread daily
Low-FODMAP rye breadLow FODMAP rye breadAs part of habitual diet participants are expected to consume 100-200 grams of low-FODMAP rye bread daily
Primary Outcome Measures
NameTimeMethod
Change is IBS symptoms by using IBS-SSS questionaire4 weeks
Secondary Outcome Measures
NameTimeMethod
IBS quality of life by using IBS QoL questionnaire4 weeks
Changes in specific IBS symptoms measured by 100 mm VAS scale4 weeks
Changes is intestinal microbiota evaluated by fecal samples4 weeks
Changes in hydrogen excretion evaluated by 6 hours breath test after standard rye bread breakfast4 weeks

Trial Locations

Locations (1)

Aava Medical Centre

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath